Inhaled zanamivir, a potent and selective inhibitor of influenza A and B virus neuraminidases, is effective in treating acute influenza in adults and adolescents. 8–10 In addition, seasonal ...

Cite this: Zanamivir for the Treatment of Clinically Diagnosed Influenza in Clinical Practice: Results of the Valuable-Insights-From-Patients Study - Medscape - Nov 01, 2000.

Correspondence Zanamivir to Prevent Influenza Published February 15, 2001 N Engl J Med 2001;344: 528 - 530 DOI: 10.1056/NEJM200102153440714 ...

The large study enrolled 865,032 outpatients treated with inhaled zanamivir (n = 595,897) or oral oseltamivir (269,135) within 48 hours of being diagnosed with influenza.

Objective To review the clinical effectiveness of oseltamivir and zanamivir for the treatment and prevention of influenza A and B. Design Systematic review and meta-analyses of randomised controlled ...

Naoki Kawai, Hideyuki Ikematsu, Nobuo Hirotsu, Tetsunari Maeda, Takashi Kawashima, Osame Tanaka, Satoshi Yamauchi, Kenichi Kawamura, Shinro Matsuura, Mika Nishimura, Norio Iwaki, Seizaburo Kashiwagi, ...

Objective: To extend these data by assessing patients' perceptions of zanamivir in clinical practice during the 1999 to 2000 influenza season in the USA. Design: Telephone survey of patients or ...